The global nanopharmaceutical drugs market is projected to be worth USD 82.71 Billion by 2027, according to a current analysis by Emergen Research. The nanopharmaceutical drugs market is observing high demand attributed to the rising incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease. The advantages offered by nanopharmaceutical drugs comprise targeting lesions/tumor cells, apoptosis commencement, and drug accumulation in specific tissue for improved cancer cells’ exposure cells. Existing pharmaceuticals formulation into the nanoscale has resulted in lower toxicity levels and better cell specificity.
You Can Download Free Sample PDF Copy of Nanopharmaceutical Drugs Market at https://www.emergenresearch.com/request-sample/378
The research provides answers to the following key questions:
What is the estimated market size and growth rate of the Nanopharmaceutical Drugs market for the forecast period, 2020 – 2027?
What are prominent factors driving the progress of the Nanopharmaceutical Drugs industry across different regions?
Who are major vendors dominating the Nanopharmaceutical Drugs market and what have been their winning strategies to stay competitive?
Which market trends are expected to influence the development of the Nanopharmaceutical Drugs industry worldwide?
What are challenges that are expected to act as a roadblock for Nanopharmaceutical Drugs industry for the period, 2020 – 2027?
What are the opportunities working in favor of the Nanopharmaceutical Drugs industry?
This report on the global Nanopharmaceutical Drugs Market equips the reader with all essential tools to decipher their standing in the industry based on the growth of revenue or sales. It provides a comprehensive evaluation of the global Nanopharmaceutical Drugs market from various perspectives to deliver a detailed, informative, and precise analysis of regional growth, competition, and market segmentation, among other factors. Moreover, it also gives an accurate account of the significant breakthroughs and developments that influence the global Nanopharmaceutical Drugs market. It also focuses on both the global as well as the regional expansion of the Nanopharmaceutical Drugs industry to give an overall analysis.
Get access to FREE Sample PDF Copy of Nanopharmaceutical Drugs Market at https://www.emergenresearch.com/request-sample/378
Key Highlights From The Report
In February 2019, Sanofi entered into a definitive agreement with NH TherAGuIX for the introduction of AGuIX® Nanoparticle in the field of cancer treatment. This agreement offers NH TherAGuIX the benefit to gain from the experience and industrial expertise of Sanofi in producing active pharmaceutical ingredients (API).
Microemulsion formulations are considered to be advantageous compared to conventional oral formulations and provide improved absorption, increased clinical potency, and decreased drug toxicity.
The application of nanotechnologies has extremely transformed the pharmaceutical and biotechnology sector landscape, with nearly 100 nanomedicine products at present being sanctioned for clinical use varying from drug delivery to and medical devices.
Nanopharmaceutical drugs for antimicrobial drug delivery provide unique benefits in reducing resistance and triggering fewer side effects compared to conventional antibiotics. Nanopharmaceutical drugs can induce efficient immune responses compared to microbial infection.
The market in the North American region held the largest market share in 2019, owing to high adoption of advanced diagnostic procedures, a rising incidence of chronic conditions, established healthcare infrastructure, and undertaking of various initiatives to create awareness about the disease.
Key participants include Amgen Inc., AstraZeneca PLC, Gilead Sciences Inc., Novartis AG, F. Hoffmann-La Roche AG, AbbVie Inc., Johnson & Johnson, Pfizer Inc., Sanofi SA, and Merck & Co. Inc., among others.
Type Outlook (Revenue, USD Billion; 2017-2027)
Solid Lipid Nanoparticles
Application Outlook (Revenue, USD Billion; 2017-2027)
Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Retail Off-Line Pharmacies
Retail On-Line Pharmacies
Regional Outlook (Revenue, USD Billion; 2017-2027)
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Nanopharmaceutical Drugs Market Segmentation & Impact Analysis
Chapter 5. Nanopharmaceutical Drugs Market By Product Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)
Chapter 6. Nanopharmaceutical Drugs Market By Surgery Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 7. Nanopharmaceutical Drugs Market By End User Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 8. Nanopharmaceutical Drugs Market Regional Outlook
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
State: British Columbia